|
Market Closed -
Nasdaq
00:00:00 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 19.25 USD | -0.93% |
|
-8.55% | +12.08% |
| 09-22 | Top Midday Gainers | MT |
| 09-22 | Omeros Shares Rise After Cantor Fitzgerald Upgrade | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.41B | - | - | - | - | |
| 71.81B | |||||
| 60.06B | |||||
| 27.93B | |||||
| 25.7B | - | ||||
| 24.89B | - |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
